142
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Stability-Indicating HPTLC Method for Quantitative Estimation of Asenapine Maleate in Pharmaceutical Formulations, Equilibrium Solubility, and ex vivo Diffusion Studies

, &

References

  • Van Der Sterren, J. E. M.; Van Den Heuvel, D. J. M. Intranasal Administration of Asenapine and Pharmaceutical Compositions Therefore, 2008, US 2008/0306133 A1.
  • Indian Pharmacopoeia (IP 2014), 7th Edition, Indian Pharmacopoeial Commission, Ghaziabad, India, 2014, pp. 1088–1089.
  • Chhalotiya, U. K.; Bhatt, K. K.; Shah, D. A.; Patel J. R. Stability Indicating Liquid Chromatographic Method for the Quantification of the New Antipsychotic Agent Asenapine in Bulk and in Pharmaceutical Formulation. Sci. Pharm. 2012, 80, 407–417.
  • Nagarajan, G.; Koulagari, S.; Methuku, A.; Podhuturi, S.; Venkata, R. B. Method Development and Validation of RP-HPLC Method Determination of New Antipsychotic Agent Asenapine Maleate in Bulk and in Pharmaceutical Formulation. Der. Pharm. Let. 2012, 4, 1805–1810.
  • Parthasarathi, T. R.; Srinivas, T. S.; Sri, M. V.; Ram, S. S.; Basha, M. M.; Pudi, R. Quantitative Determination of Asenapine Maleate Using Reverse Phase-High Performance Liquid Chromatography. Int. J. Pharm. BioSci. 2012, 3, 360–366.
  • Aneesh, T. P.; Rajasekaran, A. Stress Degradation Studies and Development and Validation of RP-HPLC Method for the Estimation of Asenapine Maleate. Int. J. Pharm. Pharm. Sci. 2012, 4, 448–451.
  • Kumaraswamy, S. M. L. Swapna, M. Development and Validation of RP HPLC Method for the Estimation of Asenapine in Bulk and Tablet Dosage Form. Contemp. Invest. Obs. Pharm. 2013, 2, 79–84.
  • Yanamadala, G.; Gupta, R. V.; Srikumar, P. P.; Rusyendra, G. V.; Lavanya, N. Development and Validation of RPHPLC Method for the Estimation of Asenapine Maleate in Bulk and Pharmaceutical Formulation. Asian J. Pharm. Anal. Med. Chem. 2013, 1, 132–139.
  • Aarelly, K.; Thimmaraju, M. K.; Nerella, R.; Allabotharam, S. Method Development and Validation of Asenapine in Bulk by RP-HPLC Method. J. Chem. Pharma. Res. 2012, 4, 2580–2584.
  • Narke, R.; Mandlik, S.; Kapure, S. Bioanalytical Development and Validation of Stability-Indicating RP-HPLC Method for the Estimation of Asenapine Maleate in Plasma. Inventi Rapid Biomed. Anal. 2014, 2014, 13879.
  • Chander, P.; Mehta, T. HPLC-UV Method for the Determination of Asenapine Maleate Impurities Using a Solid Core C8 Column. Thermo Fisher Sci. Inc. Appl. Note. 2013, 20739.
  • Van de Wetering-Krebbers, S. F. M.; Jacobs, P. L.; Kemperman, G. J.; Spaans, E.; Peters, P. A. M.; Delbressine, L. P. C.; Van Iersel, M. L. P. S. Metabolism and Excretion of Asenapine in Healthy Male Subjects. Drug Metabol. Dispos. 2011, 39, 580–590.
  • De Boer, T.; Meulman, E.; Meijering, H.; Wieling, J.; Dogterom, P.; Lass, H. Quantification of Asenapine and Three Metabolites in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry with Automated Solid Phase Extraction: Application to a Phase I Clinical Trial with Asenapine in Healthy Male Subjects. Biomed. Chromatogr. 2012, 56, 156–165.
  • Miller, C.; Pleitez, O.; Mertens-Maxham, D.; Wade, N. GC–MS Method Validation and the Postmortem Distribution of a New Atypical Antipsychotic Medication. J. Anal. Toxicol. 2013, 37, 559–564.
  • Mrudulesh, Y.; Shankar, P. R.; Devadasu, C. H.; Srinivasa, B. P. Development of a Validated UV Spectrophotometric Method for the Quantitative Estimation of Asenapine Maleate in Bulk Drug. J. Chem. Pharm. Sci. 2013, 6, 227–230.
  • Aneesh, T. P.; Halima, O. A.; Ghosh, A.; Thomas, N. R. Development and Validation of UV Spectrophotometric Method for the Estimation of Asenapine Maleate in Bulk and Pharmaceutical Formulation. Der. Pharm. Chem. 2012, 4, 644–649.
  • Gandhimathi, R.; Vijayraj, S.; Jyothirmaie, M. P. Method Development and Validation of UV Spectrophotometric Method for the Estimation of Asenapine Maleate in Bulk and Pharmaceutical Formulation. Int. J. Med. Chem. Anal. 2012, 2, 85–90.
  • Aarelly, K.; Thimmaraju, M. K.; Nerella, R. Quantitative Determination of Asenapine in Both Bulk and Formulations Using Neutralization Titrations. J. Appl. Pharm. Sci. 2012, 2, 141–145.
  • El-Koussi, W. M.; Atia, N. N.; Mahmouda, A. M.; El-Shabouri, S. R. HPTLC Method for Direct Determination of Gemifloxacin Mesylate in Human Plasma. J. Chromatogr. B. 2014, 967, 98–101.
  • Gopani, M.; Patel, R. B.; Patel, M. R.; Solanki, A. B. Development of a New High-Performance Thin Layer Chromatographic Method for Quantitative Estimation of Lamivudine and Zidovudine in Combined Tablet Dosage Form Using Quality by Design Approach. J. Liq. Chromatogr. Rel. Technol. 2014, 37, 2420–2432.
  • Patel, R. B.; Patel, M. R.; Dubey, N.; Dubey, N.; Patel, B. HPTLC Method Development and Validation: Strategy to Minimize Methodological Failures. J. Food Drug Anal. 2012, 20, 561–570.
  • Patel, R. B.; Patel, M. R.; Bhatt, K. K.; Patel, B. G. HPTLC Method Development and Validation: Quantification of Paliperidone in Formulations and in Vitro Release Study. Anal. Methods. 2010, 2, 525–531.
  • Shewiyo, D. H.; Kaale, E.; Risha, P. G.; Dejaegher, B.; Smeyers-Verbeke, J.; Vander Heyden, Y. HPTLC Methods to Assay Active Ingredients in Pharmaceutical Formulations: A Review of the Method Development and Validation Steps. J. Pharm. Biomed. Anal. 2012, 66, 11–23.
  • Patel, R. B.; Patel, M. R.; Patel, B. G. Development and Validation of HPTLC Method for Determination of Olanzepine in Formulations. J. AOAC Int. 2010, 93, 811–819.
  • Patel, R. B.; Patel, M. R.; Patel, B. G. Experimental Aspects and Implementation of HPTLC. In High Performance Thin Layer Chromatography (HPTLC); Srivastava, M. M. Ed.; Springer-Verlag Berlin Heidelberg: New York, NY, 2011, 41–54 pp.
  • International Conference on Harmonization (ICH). Validation of Analytical Procedure: Text and Methodology Q2 (R1); IFPMA: Geneva, Switzerland, 2005.
  • Patel, R. B.; Patel, M. R.; Bhatt, K. K.; Patel, B. G. Risperidone Loaded Mucoadhesive Microemulsion for Intranasal Delivery: Formulation Development, Physicochemical Characterization and Ex Vivo Evaluation. J. Drug Del. Sci. Technol. 2013, 23, 561–567.
  • Patel, M. R.; Patel, R. B.; Bhatt, K. K.; Patel, B. G.; Gaikwad, R. V. Paliperidone Microemulsion for Nose-To-Brain Targeted Drug Delivery System: Pharmacodynamic and Pharmacokinetic Evaluation. Drug Del. 2014. doi:10.3109/10717544.2014.914602.
  • Kurmi, M.; Kumar, S.; Singh, B.; Singh, S. Implementation of Design of Experiments for Optimization of Forced Degradation Conditions and Development of a Stability-Indicating Method for Furosemide. J. Pharm. Biomed. Anal. 2014, 96, 135–143.
  • Kumar, V.; Bhutani, H.; Singh, S. ICH Guidance in Practice: Validated Stability-Indicating HPLC Method for Simultaneous Determination of Ampicillin and Cloxacillin in Combination Drug Products. J. Pharm. Biomed. Anal. 2007, 43, 769–773.
  • Patel, R. B.; Patel, M. R.; Goswami, T. S. Stability-Indicating HPTLC Method for Estimation of Bamifylline Hydrochloride in Tablet Formulation: Development and Validation Consideration. Thai J. Pharm. Sci. 2014, 38, 168–175.
  • Ferenczi, K.; Renger, B.; Vegh, Z. The Frustrated Reviewer – Recurrent Failures in Manuscript Describing Validation of Quantitative TLC/HPTLC Procedure for Analysis of Pharmaceuticals. J. Planar Chromatogr. 2010, 23, 173–179.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.